Press Contacts

Caroline Liou/UW Department of Global Health 
Communication Manager 
tel: 206.616.0130
Box 357965
cliou1@uw.edu


 

The latest news

COVID-19: CDC Advisory Committee Hones in on Vaccine Rollout Recommendations (includes Beth Bell)

Jake EllisonUW News

When a vaccine to fight COVID-19 has been approved by the FDA for distribution, it’s unlikely that at first there will be enough doses for everyone. Consequently, the United States will need an equitable and effective plan for who gets those first doses, how they get them and who’s next.

Just as important, that plan — like the vaccine itself — has to be trusted and accepted by the general public.

Video: Preserving the Scientific Integrity of Getting to COVID-19 Vaccines: From Clinical Trials to Public Allocation

More than 5,200 viewers joined us last week for the Johns Hopkins University–University of Washington symposium “Preserving the Scientific Integrity of Getting to COVID-19 Vaccines: From Clinical Trials to Public Allocation.”

Thank you to those who watched and heard from prominent experts, including scientists from JHU and the UW, who provided insight into the scientific process around developing effective and safe vaccines for COVID-19, and the importance of maintaining scientific integrity and public trust.

50 Changemakers of Public Health

To celebrate the UW School of Public Health’s 50 years of impact, the School is recognizing 50 alumni from around the world who have a demonstrated record of distinguished service and achievement across public health disciplines and settings. These 50 Changemakers of Public Health are leaders, trailblazers, educators, innovators, influencers and health equity heroes that represent just a slice of the School’s community of more than 10,000 alumni worldwide who are addressing some of the most pressing population health issues of our time.

Researchers Recruiting Patients for Regeneron Antibody Trial (includes Ruanne Barnabas)

UW Medicine, Fred Hutch scientists will jointly test whether the monoclonal drug can prevent infection among people exposed to COVID-19.

Researchers at UW Medicine and the Fred Hutchinson Cancer Research Center are jointly testing monoclonal antibodies created by Regeneron Pharmaceuticals to prevent COVID-19, and are starting to recruit patients.